Toggle News Sections
Press release: Push For Lower Rx Prices: Over 70 Organizations Call For Meaningful Progress On Comprehensive Drug Pricing Reforms By Memorial Day
Click for PDF version FOR IMMEDIATE RELEASE Doctors for America PO Box 53313 1921 Florida Ave NW Washington, DC 20009-9997 Candy Tai Communications Manager Doctors for America [email protected] Push…
Read PostPress Release: Doctors for America Hosts Day of Action Advothon to Put Constituents First and Support Access to Affordable Health Care
Click here to download a PDF of this press release FOR IMMEDIATE RELEASE Doctors for America PO Box 53313 1921 Florida Ave NW Washington, DC 20009-9997 Candy Tai Digital Communications…
Read PostPublic Comment from Doctors for America to the Centers for Medicare and Medicaid Services on “Proposed National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease” (CAG-00460N)
Doctors for America commends the Centers for Medicare and Medicaid Services (CMS) for their proposed national coverage decision regarding “Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease”…
Read PostWritten Testimony of Reshma Ramachandran, M.D., M.P.P. at Hearing on “FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics” Subcommittee on Health
Written Testimony of Reshma Ramachandran, M.D., M.P.P. of Yale School of Medicine Hearing on “FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics” Subcommittee on Health U.S. House…
Read PostThe Centenary of Insulin: Celebrating the Past, Analyzing the Present, and Looking into the Future
by: David Hirsch, MD and Aruna Muthumanickam, MBBS The discovery of insulin in 1921 revolutionized the medical treatment of diabetes, which until then had been a fatal disease. By 1922,…
Read PostKeeping the Facts of Drug Pricing Proposals Straight
As debate over the federal Build Back Better budget reconciliation package continues this autumn, your legislators in Washington, DC need to hear from YOU. DFA has put together a letter,…
Read PostThe Omnipresent Drug Affordability Crisis: Stories from Across the Seas
by: Aruna Muthumanickam, MD It was an unremarkable Tuesday afternoon during my Internal Medicine inpatient rotation in a small village town in India called Talegaon. The ward stretched before me,…
Read PostHHS plan to lower prescription drug costs is a good start, but we need bold, swift action
Republished with permission from original source Healio. By Rita K. Kuwahara, MD, MIH HHS recently announced a plan supporting legislation that would allow it to negotiate Medicare Part B and Part D…
Read PostThe U.S. Drug Pricing Problem: How Did We Get Here?
by Dhiksha Balaji In the United States, we spend more on prescription medications than any other country – even though we don’t use more than others. And medications are only becoming more expensive. Between the years…
Read PostPrescription Drug Affordability Boards and State-Led Effort to Control Drug Pricing
by David Hirsh Unlike other comparable countries, in the United States, prescription drugs prices are not set or regulated by the federal government. The out-of-pocket costs that patients face for…
Read Post